CPHI Milan
CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages is the world’s largest pharma event bringing more than 62,000 professionals and 2,400 exhibitors from more than 166 countries.
The exhibition, which will take place from 8-10 October 2024, and is being hosted in Milan, Italy in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region.
Date: October 8-10, 2024
Location: Fiera Milano, Milan, Italy
Booth Number: 7A2
Build Your Path to Success with Catalent at CPHI Milan 2024!
We’re pleased to share that Catalent will be exhibiting at CPHI Milan 2024 (Catalent stand 7A2), and we look forward to the opportunity to collaborate with you in bringing your Pharma, Biologics, and Consumer Health products to clinic and market. Whether you’re an existing partner or exploring new opportunities, our team is here to support your journey.
Why Visit Us?
Discover how Catalent can accelerate your product’s journey from concept to market with our cutting-edge solutions and unrivaled expertise. You will learn about our customizable services that cater to the unique needs of your business in Pharma, Biologics, and Consumer Health.
Meet Our Experts
Want to dive deeper? Schedule a one-on-one meeting with Catalent’s industry experts during CPHI Milan. Simply complete the form, and we’ll arrange a time to discuss how we can help you achieve your goals.
Special Offer: Free Access Pass!
As a valued guest, we’re offering you an exclusive chance to attend CPHI for FREE. Don’t miss out—register before mid-September and secure your complimentary access pass! Spots are limited, so click here to register and secure your free pass today!
ABOUT CATALENT
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information www.catalent.com.
